Digital clinical diagnostics and diabetes home testing provider Digostics and Medway NHS Foundation Trust (MFT), announced today a partnership that will see the Trust become the latest maternity services provider to extend new remote oral glucose tolerance testing (OGTT) to all expectant mothers who are at risk of developing gestational diabetes mellitus (GDM).  The collaboration will involve the full implementation of GTT@home, the world’s first commercially available ho

Ubie, a global healthcare AI platform that works at the intersection of patients, providers, and life sciences to guide everyone to better care, and the American Kidney Fund (AKF), the nonprofit with the greatest direct impact on people with kidney disease, today announced a collaboration focused on assessing and fine-tuning Ubie's Symptom Checker disease prediction AI with the goal of driving patients to faster diagnosis, allowing them to receive faster treatment earlier in the disease p

DecisionRx, a value-based healthcare company reducing the cost of care by helping individuals eliminate medication failure, announced today a collaboration with AmeriLife Group, LLC (“AmeriLife”), a leading provider of insurance and retirement solutions, to provide Medicare Advantage and Medicare Supplement patients access to its Medication Therapy Optimization (MTO) platform. The DecisionRx MTO platform provides patients and providers with an analysis of which medications wo

EvoEndo®, Inc. (EvoEndo) is excited to announce the release of the Model LE 85 Single-Use Gastroscope, providing an additional option for Sedation-Free Transnasal Endoscopy (TNE) of the Upper Gastrointestinal Tract. The Model LE 85 Single-Use Gastroscope is designed to offer maximum patient comfort and physician control when access to the duodenum is not required. It features a shorter shaft length and enhanced flexibility while maintaining all the functionality of the Model LE

Sumitomo Corporation, through its U.S. subsidiary Sumitomo Corporation of Americas (SCOA), announced an investment in Vast Medical Holdings, which owns Quest Health Solutions (Quest). This transaction marks Sumitomo Corporation Group’s entry into the U.S. healthcare market and represents a strategic move to enhance interventions and manage the needs of chronic-care patients. Chronic diseases, including diabetes, significantly impact the U.S. population. According to the Center

Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems, has announced that it has received conditional IDE approval from the U.S. Food and Drug Administration to begin the ATHENA study of its ANA Funnel Catheter. The prospective, randomized, dual-arm, multi-center study will assess the safety and effectiveness of mechanical thrombectomy using the ANA Funnel Catheter in combination with a stent retriever. “The neurointerventional comm

Syra Health Corp. (NASDAQ: SYRA) (“Syra Health” or the “Company”), a healthcare technology company powering better health by providing meaningful solutions, announced today that it is giving away its AI developed by the Company for redacting personally identifiable information in line with HIPAA regulations. Syra Health is giving the configurable solution to the healthcare and technology community for its use in redacting personally identifiable information or for expa

AMN Healthcare, the leader and innovator in total talent solutions for healthcare organizations, launched the Manager Hub app, the latest innovative capability of its workforce management platform, ShiftWise Flex™. This additional functionality empowers healthcare organizations with on-the-go, accessible workforce management capabilities. ShiftWise Flex, a next-gen vendor-neutral vendor management system (VMS), serves as a comprehensive workforce management platform for healthcare organ

Guidehouse, a leading global provider of strategy and managed services to commercial and public sector clients, today announced a partnership with the Healthcare Information and Management Systems Society (HIMSS) to deploy HIMSS’ Digital Health Indicator (DHI) to assess the Missouri Department of Health and Senior Services’ (DHSS’) progress toward digital health transformation.  The public health data landscape survey and strategic transformation maturity asse

Hyperfine, the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared portable magnetic resonance (MR) brain imaging system—the Swoop® system—today highlights the results from a multi-site observational study that showed the value of using Swoop® system images to quickly assess stroke patients and help guide physicians making critical treatment decisions. This publication marks the first to include a subset of ACTION PMR study